Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy

Depression affects about 121 million people worldwide and prevalence of major depressive disorder (MDD) in US adults is 6.4%. Treatment resistant depression (TRD) accounts for approximately 12–20% of all depression patients and costs $29–$48 billion annually. Ketamine and repetitive transcranial mag...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Basant, Parikh, Tapan, Makani, Ramkrishna, Sahoo, Madhusmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609854/
https://www.ncbi.nlm.nih.gov/pubmed/26509083
http://dx.doi.org/10.1155/2015/842817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609854/
https://www.ncbi.nlm.nih.gov/pubmed/26509083
http://dx.doi.org/10.1155/2015/842817

Ejemplares similares